Differentiated thyroid carcinoma (DTC) has been increasing in incidence in the United
States over the last several decades, although mortality rates have remained low …

The hypothalamic–pituitary–thyroid axis plays a crucial role in the pathogenesis, diagnosis,
risk stratification, effectiveness of radioiodine therapy, and treatment response evaluation in …

Objective To develop and validate a radiomics-clinical combined model combining
preoperative computed tomography (CT) and clinical data from patients with papillary …

Importance Radioactive iodine (131 I or RAI) therapy has long been the standard of care for
most patients with differentiated thyroid cancer (DTC) after primary surgery. However, no …

Background Existing epidemiological data indicated a correlation between thyroid cancer
(THCA) and the risk of secondary primary malignancies (SPMs). However, the correlation …

Background/Objectives: The management of differentiated thyroid cancer (DTC) patients has
undergone a major paradigm shift in past years, especially regarding the role of a careful …

Molecular imaging is pivotal in evaluating and managing patients with different thyroid
cancer histotypes. The existing, pathology-based, risk stratification systems can be usefully …

Background: This study aimed to investigate the effect of incentive nursing care (ICN) as a
supplementary therapy to routine nursing care (RNC) on depression and anxiety (DA) in …

Background This meta-analysis and systematic review aimed to evaluate the therapeutic
efficacy and advantages associated with the use of recombinant human thyroid-stimulating …

Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid cancer (TC).
Although surgery and radioactive iodine therapy (RAI) generally yield favorable outcomes …